
Oniria Therapeutics
Modulating cell dormancy to overcome cancer persistence
$1.4M Seed ·
Source: startupintros.com
Funding history ↓Signals
Website registeredDec 8, 2020 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $1.4M | — | startupintros.com |
Timeline
- Website created
Founders and team
- CGCarlos Galdeano Co-Founder and Scientific Advisor in drug discoverysource: oniriatherapeutics.com
- EREsther Riambau Co-Founder and Chief Executive Officersource: oniriatherapeutics.com
- HGHéctor G. Palmer Co-Founder and Chief Scientific Officersource: oniriatherapeutics.com
- IPIsabel Puig Co-Founder and Scientific Advisor for new therapeutic targetssource: oniriatherapeutics.com
- JTJosep Tabernero Co-Founder and Clinical Advisorsource: oniriatherapeutics.com
- XBXavier Barril Co-Founder and Scientific Advisor in computational chemistrysource: oniriatherapeutics.com
Companies like Oniria Therapeutics
WWittGenSeed · May 2026
IImmuno Cancer BiotherapeuticsSeed · Oct 2026
AAlethio Therapeutics$90M Series A · Nov 2026
TT-Therapeutics$133M Series B+ · Nov 2026
PPrevision Medicine$5.4M Seed · Sep 2026
RReprogram Biosciences$6M Seed · May 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/oniria-therapeutics (get a free API key).